303 Clinical and laboratory associations of longitudinal cell-bound complement activation products in SLE

Eitemau Tebyg

• Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms
  gan: David S Pisetsky, et al.
  Cyhoeddwyd: (2023-11-01)
• Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model
  gan: Amanda M. Eudy, et al.
  Cyhoeddwyd: (2024-12-01)
• Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
  gan: David S Pisetsky, et al.
  Cyhoeddwyd: (2022-07-01)
• Relationship between hydroxychloroquine blood levels and lupus activity through the lens of the type 1 and type 2 lupus model: a cross-sectional study
  gan: Rebecca E Sadun, et al.
  Cyhoeddwyd: (2025-06-01)
• Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study
  gan: Kai Sun, et al.
  Cyhoeddwyd: (2023-12-01)